
Verve Therapeutics, Inc.
USD11.13
+0.03 (+0.27%)
CEO
Sekar Kathiresan
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.13
Prev. Close
$11.10
Day Low
$11.13
Day High
$11.13
52W Low
$2.87
52W High
$11.40
Market Cap
$0.99B
Volume
10.31M
| 18 Jun 2025 |
| Jefferies |
| Buy |
| Hold |
| downgrade |
| 17 Jun 2025 | Canaccord Genuity | Buy | Hold | downgrade |
| 17 Jun 2025 | William Blair | Outperform | Market Perform | downgrade |
| 15 Apr 2025 | Canaccord Genuity | Buy | Buy | maintain |
| 15 Apr 2025 | Guggenheim | Buy | Buy | maintain |
| 15 Apr 2025 | William Blair | Outperform | Outperform | maintain |
| 15 Apr 2025 | Cantor Fitzgerald | Neutral | Overweight | upgrade |